Attached files

file filename
EX-31.2 - EXHIBIT 31.2 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20151231xexhibit312.htm
EX-3.01 - EXHIBIT 3.01 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela20151231exhibit301.htm
EX-3.02 - EXHIBIT 3.02 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela20151231exhibit302.htm
EX-10.25 - EXHIBIT 10.25 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela20151231exhibit1025.htm
EX-21.1 - EXHIBIT 21.1 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela20151231exhibit211.htm
EX-23.1 - EXHIBIT 23.1 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20151231xexhibit231.htm
EX-31.1 - EXHIBIT 31.1 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20151231xexhibit311.htm
EX-10.26 - EXHIBIT 10.26 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela20151231exhibit1026.htm
EX-32.2 - EXHIBIT 32.2 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20151231xexhibit322.htm
EX-10.16 - EXHIBIT 10.16 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20151231exhibit1016.htm
10-K - 10-K - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela2015q410k.htm
EX-10.17 - EXHIBIT 10.17 - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela20151231exhibit1017.htm

Exhibit 32.1


CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 


I, Ryo Kubota, M.D., Ph.D., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge, the annual report of Acucela Inc. on Form 10-K for the year ended December 31, 2015 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as applicable, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Acucela Inc. for the periods presented therein.


Date:
March 10, 2016
 
/s/ Ryo Kubota, M.D., Ph.D.
 
 
 
Chairman, President and Chief Executive Officer
 
 
 
(Principal Executive Officer)